multiple and mixed valvular heart disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 18 years of age or older at the time of obtaining consent (2) Patients who have undergone echocardiography and have been diagnosed as having moderate or severe united valvular heart disease. (3) Patients who have received a thorough explanation of their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study.
Exclusion criteria
Exclusion criteria: (1) Patients with a history of valvular surgery with respect to the valve that led to the diagnosis of united valvular disease. (2) Patients diagnosed with infective endocarditis within 6 months. (3) Complex congenital heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the prevalence of multiple and mixed valvular heart disease at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| The survey will include cardiovascular deaths, non-cardiac deaths, strokes, cardiovascular events, sudden deaths, heart failure hospitalizations, and the presence and nature of treatment in progress. | — |
Countries
Japan,Asia(except Japan),North America,Europe,Africa
Contacts
Juntendo University Department of Cardiovascular Biology and Medicine